Factors Related to Delayed Adverse Events of Endoscopic Submucosal Dissection in the Duodenum

Dig Dis. 2023;41(1):80-88. doi: 10.1159/000522362. Epub 2022 Feb 2.

Abstract

Introduction: Endoscopic submucosal dissection for duodenal neoplasms (D-ESD) is considered a technically demanding procedure regarding the high risk of delayed adverse events. Data regarding optimal managements of ulcers after D-ESD are lacking.

Methods: A retrospective analysis was performed on consecutive 145 cases of D-ESD for superficial nonampullary duodenal epithelial tumors at a single referral center. Factors related to delayed adverse events and the healing process of ulcers after D-ESD were analyzed.

Results: Complete ulcer suture after D-ESD was performed in 128 cases (88%). Two delayed perforation occurred among cases with incomplete suture. Delayed bleeding occurred in 8 cases (6%) within 3 weeks. The ulcer closure rate at second-look endoscopy (SLE) was significantly low among cases with delayed bleeding (12.5% vs. 75%, p = 0.001). The bleeding rate before SLE was significantly high among patients who did not have complete ulcer closure after D-ESD (0.8% vs. 12%, p = 0.036). The ratio of lesions located in the second oral-Vater was significantly low among ulcers re-opened at SLE (38% vs. 14%, p = 0.044). Proton-pump inhibitors (PPIs) were administered for a median of 7 weeks (range 1-8 weeks). At 3 weeks, active ulcer stages were observed in a few cases, and healing or scarring was observed in most cases.

Conclusions: Complete ulcer suture was related to decreased risk of delayed adverse events after D-ESD. From the bleeding period and healing process of D-ESD ulcers, the minimum required length of PPI may be 3 weeks after D-ESD.

Keywords: Delayed bleeding; Delayed perforation; Duodenum; Endoscopic submucosal dissection; Second-look endoscopy.

MeSH terms

  • Duodenum / pathology
  • Endoscopic Mucosal Resection* / adverse effects
  • Endoscopy, Gastrointestinal / adverse effects
  • Humans
  • Proton Pump Inhibitors / adverse effects
  • Retrospective Studies
  • Stomach Neoplasms* / pathology
  • Stomach Ulcer* / pathology
  • Ulcer / chemically induced

Substances

  • Proton Pump Inhibitors

Grants and funding

None.